Khan Md Mahbubur Rahman, Sato Akira, Shimizu Akio, Suetaka Shunji, Molla Md Rasel, Komeno Masahiro, Nasrin Mst Zenika, Nishida Masanari, Toyoda Futoshi, Arai Munehito, Ogita Hisakazu
Division of Molecular Medical Biochemistry, Department of Biochemistry and Molecular Biology (M.M.R.K., A. Sato, A. Shimizu, M.R.M., M.K., M.Z.N., M.N., H.O.), Shiga University of Medical Science, Otsu, Japan.
Department of Life Sciences, Graduate School of Arts and Sciences (S.S., M.A.), The University of Tokyo, Meguro, Japan.
Arterioscler Thromb Vasc Biol. 2025 Jul;45(7):1226-1243. doi: 10.1161/ATVBAHA.125.322619. Epub 2025 May 29.
Vascular smooth muscle cells (VSMCs) regulate vascular tone and blood pressure. Stimulation of VSMCs with vasoconstrictors, such as AngII (angiotensin II) or norepinephrine, activates the G-protein-coupled receptor-mediated cascade, leading to a hypercontractile state and vascular remodeling. Afadin, an intracellular adaptor protein that mainly localizes at cell-cell junctions, regulates various biological phenomena. However, its role in VSMCs remains unclear.
VSMCs were isolated from newly generated VSMC-specific afadin conditional knockout mice. A small peptide (7 amino acids) designed in silico to inhibit the afadin-PLC (phospholipase C) β association was administered to the mouse VSMCs and aortic media using adeno-associated virus.
Unlike control mice, afadin conditional knockout mice did not exhibit AngII- or norepinephrine-induced elevation in blood pressure. VSMCs isolated from afadin conditional knockout mice were less responsive to AngII- or norepinephrine-induced cell contractility compared with control VSMCs, as evidenced by reduced release of intracellular Ca resulting from lowered production of AngII- or norepinephrine-induced inositol 1,4,5-trisphosphate. Mechanistically, the PDZ (disk large tumor suppressor, zonula occludens-1) domain of afadin was shown to associate with the C terminus of PLCβ, providing support for the localization of PLCβ on the plasma membrane, where it generates inositol 1,4,5-trisphosphate. Furthermore, the newly designed small peptide, which inhibited the afadin-PLCβ association, attenuated AngII-induced cell contractility and intracellular Ca release in vitro and blocked AngII-stimulated blood pressure elevation in vivo.
Afadin expression in VSMCs promotes cell contraction by interacting with PLCβ to enhance Ca signaling and has potential as a novel molecular target for blood pressure regulation.
血管平滑肌细胞(VSMC)调节血管张力和血压。用血管收缩剂如血管紧张素II(AngII)或去甲肾上腺素刺激VSMC,可激活G蛋白偶联受体介导的级联反应,导致超收缩状态和血管重塑。Afadin是一种主要定位于细胞间连接的细胞内衔接蛋白,可调节多种生物学现象。然而,其在VSMC中的作用仍不清楚。
从新生成的VSMC特异性afadin条件性敲除小鼠中分离出VSMC。使用腺相关病毒将通过计算机设计的一种抑制afadin与磷脂酶C(PLC)β结合的小肽(7个氨基酸)施用于小鼠VSMC和主动脉中膜。
与对照小鼠不同,afadin条件性敲除小鼠未表现出AngII或去甲肾上腺素诱导的血压升高。与对照VSMC相比,从afadin条件性敲除小鼠中分离出的VSMC对AngII或去甲肾上腺素诱导的细胞收缩反应较弱,这表现为细胞内钙离子释放减少,原因是AngII或去甲肾上腺素诱导的肌醇1,4,5-三磷酸生成减少。从机制上讲,afadin的PDZ(盘状大肿瘤抑制蛋白,紧密连接蛋白1)结构域显示与PLCβ的C末端结合,这为PLCβ定位于质膜提供了支持,在质膜上它可生成肌醇1,4,5-三磷酸。此外,新设计的抑制afadin与PLCβ结合的小肽在体外减弱了AngII诱导的细胞收缩和细胞内钙离子释放,并在体内阻断了AngII刺激的血压升高。
VSMC中afadin的表达通过与PLCβ相互作用促进细胞收缩,增强钙信号传导,并且有潜力成为血压调节的新型分子靶点。